R

Rafael Holdings
D

RFL

1.45000
USD
0.04
(2.47%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
3,332
الربح لكل سهم
0
العائد الربحي
-
P/E
-2
حجم السوق
75,399,994
نظرة عامة
أصول ذات صلة
COP
COP
D
ConocoPhillips
141.750
-0.590(-0.41%)
141.720-0.030(-0.02%)
CVX
CVX
D
شيفرون
219.390
-2.720(-1.22%)
219.490+0.100(+0.05%)
DVN
DVN
D
Devon Energy Corp
49.230
-0.690(-1.38%)
EOG
EOG
D
EOG Resources
152.660
-1.510(-0.98%)
152.670+0.010(+0.01%)
OXY
OXY
D
Occidental Petroleum Corp
60.670
-0.750(-1.22%)
60.660-0.010(-0.02%)
VLO
VLO
D
Valero Energy Corp
444.04
-15.82(-3.44%)
XOM
XOM
D
إكسون موبيل
174.645
-2.405(-1.36%)
174.700+0.055(+0.03%)
المزيد

العنوان: Rafael Holdings

القطاع: العقارات
الصناعة: Real Estate Services
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targetingtherapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.